The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Li, W., Sun, M., Zang, C., Ma, P., He, J., Zhang, M., Huang, Z., Ding, Y., & Shu, Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.126 · Cited by 179
RetractedHuang, M., Hou, J., Wang, Y., Xie, M., Wei, C., Nie, F., Wang, Z., & Sun, M. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.01.017 · Cited by 148
RetractedTissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Ohno, S. (1970) · doi:10.1007/978-3-642-86659-3 · Cited by 7,833
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“eliminate potentially transformed cells from the replicative pool.(145) Sustained K-RAS signaling promotes LATS1/MDM2/ p53-dependent apoptosis.”
BackgroundThe Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP
Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M., Jungkamp, A.-C., Munschauer, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.009 · Cited by 2,873
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells
Loh, Y.-H., Wu, Q., Chew, J.-L., Vega, V. B., Zhang, W., Chen, X., Bourque, G., George, J., Leong, B., Liu, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1760 · Cited by 2,437
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database
Chou, C.-H., Chang, N.-W., Shrestha, S., Hsu, S.-D., Lin, Y.-L., Lee, W.-H., Yang, C.-D., Hong, H.-C., Wei, T.-Y., Tu, S.-J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1258 · Cited by 1,831
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
A quantitative atlas of mitotic phosphorylation
Dephoure, N., Zhou, C., Villén, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., & Gygi, S. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805139105 · Cited by 1,608
Large-scale characterization of HeLa cell nuclear phosphoproteins
Beausoleil, S. A., Jedrychowski, M., Schwartz, D., Elias, J. E., Villén, J., Li, J., Cohn, M. A., Cantley, L. C., & Gygi, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404720101 · Cited by 1,375
The nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.037 · Cited by 1,264
The emerging roles of YAP and TAZ in cancer
Moroishi, T., Hansen, C. G., & Guan, K.-L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3876 · Cited by 1,145
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Zhao, B., Li, L., Lei, Q., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,144
Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., & Martin, J. F. (2011) · Science · doi:10.1126/science.1199010 · Cited by 1,092
Nishioka, N., Inoue, K.-I., Adachi, K., Kiyonari, H., Ota, M., Ralston, A., Yabuta, N., Hirahara, S., Stephenson, R. O., Ogonuki, N., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.02.003 · Cited by 1,078
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
Role of duplicate genes in genetic robustness against null mutations
Gu, Z., Steinmetz, L. M., Gu, X., Scharfe, C., Davis, R. W., & Li, W.-H. (2003) · Nature · doi:10.1038/nature01198 · Cited by 889
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00479-08 · Cited by 888
Hippo Pathway Activity Influences Liver Cell Fate
Yimlamai, D., Christodoulou, C., Galli, G. G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B. Z., & Camargo, F. D. (2014) · Cell · doi:10.1016/j.cell.2014.03.060 · Cited by 857
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
Zhao, B., Li, L., Wang, L., Wang, C.-Y., Yu, J., & Guan, K.-L. (2012) · Genes & Development · doi:10.1101/gad.173435.111 · Cited by 793
Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K., Rashidi, B., & Yang, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 786
Hegde, R., Srinivasula, S. M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A. S., Fernandes-Alnemri, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109721200 · Cited by 745
RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA
Kedde, M., Strasser, M. J., Boldajipour, B., Vrielink, J. A. F. O., Slanchev, K., le Sage, C., Nagel, R., Voorhoeve, P. M., van Duijse, J., Ørom, U. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.034 · Cited by 732
Epigenetic gene silencing in cancer: the DNA hypermethylome
Esteller, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm018 · Cited by 725 · cited 1×
“Promoter hypermethylation is another mechanism by which tumor suppressors are often inactivated.(70) Such mode of inactivation has been documented for LATS1, LATS2,(74,75) and in some cases for both, in various types of tumors.”
BackgroundThe Crumbs Complex Couples Cell Density Sensing to Hippo-Dependent Control of the TGF-β-SMAD Pathway
Varelas, X., Samavarchi-Tehrani, P., Narimatsu, M., Weiss, A., Cockburn, K., Larsen, B. G., Rossant, J., & Wrana, J. L. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.11.012 · Cited by 690
Embryonic stem cell–specific microRNAs regulate the G1-S transition and promote rapid proliferation
Wang, Y., Baskerville, S., Shenoy, A., Babiarz, J. E., Baehner, L., & Blelloch, R. (2008) · Nature Genetics · doi:10.1038/ng.250 · Cited by 660
Identification and consequences of miRNA–target interactions — beyond repression of gene expression
Hausser, J., & Zavolan, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3765 · Cited by 628
Subramanyam, D., Lamouille, S., Judson, R. L., Liu, J. Y., Bucay, N., Derynck, R., & Blelloch, R. (2011) · Nature Biotechnology · doi:10.1038/nbt.1862 · Cited by 598
Daub, H., Olsen, J. V., Bairlein, M., Gnad, F., Oppermann, F. S., Körner, R., Greff, Z., Kéri, G., Stemmann, O., & Mann, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.007 · Cited by 594
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208445 · Cited by 584
Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers
Lee, E. Y.-H. P., To, H., Shew, J.-Y., Bookstein, R., Scully, P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3388033 · Cited by 581
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Mo, J.-S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D.-S., & Guan, K.-L. (2015) · Nature Cell Biology · doi:10.1038/ncb3111 · Cited by 557
AMPK modulates Hippo pathway activity to regulate energy homeostasis
Wang, W., Xiao, Z.-D., Li, X., Aziz, K. E., Gan, B., Johnson, R. L., & Chen, J. (2015) · Nature Cell Biology · doi:10.1038/ncb3113 · Cited by 549
Interaction of c-Abl and p73α and their collaboration to induce apoptosis
Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 546
MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
Meng, Z., Moroishi, T., Mottier-Pavie, V., Plouffe, S. W., Hansen, C. G., Hong, A. W., Park, H. W., Mo, J.-S., Lu, W., Lu, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9357 · Cited by 530
Takahashi, A., Ohtani, N., Yamakoshi, K., Iida, S.-I., Tahara, H., Nakayama, K., Nakayama, K. I., Ide, T., Saya, H., & Hara, E. (2006) · Nature Cell Biology · doi:10.1038/ncb1491 · Cited by 528
Yin, F., Yu, J., Zheng, Y., Chen, Q., Zhang, N., & Pan, D. (2013) · Cell · doi:10.1016/j.cell.2013.08.025 · Cited by 504
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
Bonilla, X., Parmentier, L., King, B., Bezrukov, F., Kaya, G., Zoete, V., Seplyarskiy, V. B., Sharpe, H. J., McKee, T., Letourneau, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3525 · Cited by 490
A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins
Kishore, S., Jaskiewicz, L., Burger, L., Hausser, J., Khorshid, M., & Zavolan, M. (2011) · Nature Methods · doi:10.1038/nmeth.1608 · Cited by 471
Hippo signaling impedes adult heart regeneration
Heallen, T., Morikawa, Y., Leach, J., Tao, G., Willerson, J. T., Johnson, R. L., & Martin, J. F. (2013) · Development · doi:10.1242/dev.102798 · Cited by 458
Couzens, A. L., Knight, J. D. R., Kean, M. J., Teo, G., Weiss, A., Dunham, W. H., Lin, Z.-Y., Bagshaw, R. D., Sicheri, F., Pawson, T., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004712 · Cited by 441
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction
St John, M. A. R., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M. L., Brownstein, D. G., Parlow, A. F., McGrath, J., & Xu, T. (1999) · Nature Genetics · doi:10.1038/5965 · Cited by 439
Toward a comprehensive characterization of a human cancer cell phosphoproteome
Zhou, H., Di Palma, S., Preisinger, C., Peng, M., Polat, A. N., Heck, A. J. R., & Mohammed, S. (2013) · Journal of Proteome Research · doi:10.1021/pr300630k · Cited by 438
Polarity-Dependent Distribution of Angiomotin Localizes Hippo Signaling in Preimplantation Embryos
Hirate, Y., Hirahara, S., Inoue, K.-I., Suzuki, A., Alarcon, V. B., Akimoto, K., Hirai, T., Hara, T., Adachi, M., Chida, K., et al. (2013) · Current Biology · doi:10.1016/j.cub.2013.05.014 · Cited by 426
Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity
Strano, S., Munarriz, E., Rossi, M., Castagnoli, L., Shaul, Y., Sacchi, A., Oren, M., Sudol, M., Cesareni, G., & Blandino, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010484200 · Cited by 422
MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation
Praskova, M., Xia, F., & Avruch, J. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.006 · Cited by 422
Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., & O'Neill, E. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.008 · Cited by 416
Expression divergence between duplicate genes
Li, W.-H., Yang, J., & Gu, X. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.08.006 · Cited by 379
Liu, X., Sempere, L. F., Ouyang, H., Memoli, V. A., Andrew, A. S., Luo, Y., Demidenko, E., Korc, M., Shi, W., Preis, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39566 · Cited by 373
Cytokinesis Failure Triggers Hippo Tumor Suppressor Pathway Activation
Ganem, N. J., Cornils, H., Chiu, S.-Y., O’Rourke, K. P., Arnaud, J., Yimlamai, D., Théry, M., Camargo, F. D., & Pellman, D. (2014) · Cell · doi:10.1016/j.cell.2014.06.029 · Cited by 373
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
Moroishi, T., Park, H. W., Qin, B., Chen, Q., Meng, Z., Plouffe, S. W., Taniguchi, K., Yu, F.-X., Karin, M., Pan, D., et al. (2015) · Genes & Development · doi:10.1101/gad.262816.115 · Cited by 369
Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
Oka, T., Mazack, V., & Sudol, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804380200 · Cited by 367
Strano, S., Monti, O., Pediconi, N., Baccarini, A., Fontemaggi, G., Lapi, E., Mantovani, F., Damalas, A., Citro, G., Sacchi, A., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.008 · Cited by 360
Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins
Carmena, M., Ruchaud, S., & Earnshaw, W. C. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.09.008 · Cited by 349
Levy, D., Adamovich, Y., Reuven, N., & Shaul, Y. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.022 · Cited by 347
MEN and SIN: what's the difference?
Bardin, A. J., & Amon, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099020 · Cited by 344
Phosphorylation Dynamics during Early Differentiation of Human Embryonic Stem Cells
Van Hoof, D., Muñoz, J., Braam, S. R., Pinkse, M. W. H., Linding, R., Heck, A. J. R., Mummery, C. L., & Krijgsveld, J. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.021 · Cited by 323
A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway
Mohseni, M., Sun, J., Lau, A., Curtis, S., Goldsmith, J., Fox, V. L., Wei, C., Frazier, M., Samson, O., Wong, K.-K., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2884 · Cited by 294
A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization
Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., & Oren, M. (2006) · Genes & Development · doi:10.1101/gad.1447006 · Cited by 284
Self-citationLin, C.-W., Chang, Y.-L., Chang, Y.-C., Lin, J.-C., Chen, C.-C., Pan, S.-H., Wu, C.-T., Chen, H.-Y., Yang, S.-C., Hong, T.-M., et al. (2013) · Nature Communications · doi:10.1038/ncomms2876 · Cited by 281
Takahashi, Y., Miyoshi, Y., Takahata, C., Irahara, N., Taguchi, T., Tamaki, Y., & Noguchi, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1773 · Cited by 279
Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Ma, B., Chen, Y., Chen, L., Cheng, H., Mu, C., Li, J., Gao, R., Zhou, C., Cao, L., Liu, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3073 · Cited by 266
Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity
Tao, W., Zhang, S., Turenchalk, G. S., Stewart, R. A., St John, M. A. R., Chen, W., & Xu, T. (1999) · Nature Genetics · doi:10.1038/5960 · Cited by 263
Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway
Das Thakur, M., Feng, Y., Jagannathan, R., Seppa, M. J., Skeath, J. B., & Longmore, G. D. (2010) · Current Biology · doi:10.1016/j.cub.2010.02.035 · Cited by 258
Allelotype of human ovarian cancer.
Sato, T., Saito, H., Morita, R., Koi, S., Lee, J. H., & Nakamura, Y. (1991) · PubMed · Cited by 253
Hippo signaling in Drosophila: Recent advances and insights
Staley, B. K., & Irvine, K. D. (2012) · Developmental Dynamics · doi:10.1002/dvdy.22723 · Cited by 249
Li, W., Cooper, J., Zhou, L., Yang, C., Erdjument-Bromage, H., Zagzag, D., Snuderl, M., Ladanyi, M., Hanemann, C. O., Zhou, P., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.001 · Cited by 243
Protein kinases of the Hippo pathway: Regulation and substrates
Avruch, J., Zhou, D., Fitamant, J., Bardeesy, N., Mou, F., & Barrufet, L. R. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.07.002 · Cited by 228
Wan, L., Sun, M., Liu, G.-J., Wei, C.-C., Zhang, E.-B., Kong, R., Xu, T.-P., Huang, M.-D., & Wang, Z.-X. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0707 · Cited by 227
Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics
Pan, C., Olsen, J. V., Daub, H., & Mann, M. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900285-mcp200 · Cited by 220
Kim, M., Kim, M., Lee, S., Kuninaka, S., Saya, H., Lee, H., Lee, S., & Lim, D. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.102 · Cited by 217
Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
Ouillette, P., Erba, H., Kujawski, L., Kaminski, M., Shedden, K., & Malek, S. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3105 · Cited by 213
LATS tumor suppressor: A new governor of cellular homeostasis
Visser, S., & Yang, X. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13386 · Cited by 202
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity
McPherson, J. P., Tamblyn, L., Elia, A., Migon, E., Shehabeldin, A., Matysiak‐Zablocki, E., Lemmers, B., Salmena, L., Hakem, A., Fish, J., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600371 · Cited by 201
Lats2, a putative tumor suppressor, inhibits G1/S transition
Li, Y., Pei, J., Xia, H., Ke, H., Wang, H., & Tao, W. (2003) · Oncogene · doi:10.1038/sj.onc.1206603 · Cited by 199
Lee, D.-H., Park, J. O., Kim, T.-S., Kim, S.-K., Kim, T.-H., Kim, M.-C., Park, G. S., Kim, J.-H., Kuninaka, S., Olson, E. N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11961 · Cited by 196
A crucial role of WW45 in developing epithelial tissues in the mouse
Lee, J., Kim, T., Yang, T., Koo, B., Oh, S., Lee, K., Oh, H., Lee, S., Kong, Y., Kim, J., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.63 · Cited by 194
KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases
Xiao, L., Chen, Y., Ji, M., & Dong, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173468 · Cited by 190
Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
Lee, J. H., Kavanagh, J. J., Wildrick, D. M., Wharton, J. T., & Blick, M. B. (1990) · PubMed · Cited by 190
LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1
Yang, X., Yu, K., Hao, Y., Li, D.-M., Stewart, R., Insogna, K. L., & Xu, T. (2004) · Nature Cell Biology · doi:10.1038/ncb1140 · Cited by 187
MiR-93 enhances angiogenesis and metastasis by targeting LATS2
Fang, L., Du, W. W., Yang, W., Rutnam, Z. J., Peng, C., Li, H., O'Malley, Y. Q., Askeland, R. W., Sugg, S., Liu, M., et al. (2012) · Cell Cycle · doi:10.4161/cc.22670 · Cited by 186
The human tumour suppressor LATS1 is activated by human MOB1 at the membrane
Hergovich, A., Schmitz, D., & Hemmings, B. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.244 · Cited by 185
The Hippo Signaling Pathway Interactome
Kwon, Y., Vinayagam, A., Sun, X., Dephoure, N., Gygi, S. P., Hong, P., & Perrimon, N. (2013) · Science · doi:10.1126/science.1243971 · Cited by 176
Zyxin Links Fat Signaling to the Hippo Pathway
Rauskolb, C., Pan, G., Reddy, B. V. V. G., Oh, H., & Irvine, K. D. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000624 · Cited by 176
Lee, K.-H., Goan, Y.-G., Hsiao, M., Lee, C.-H., Jian, S.-H., Lin, J.-T., Chen, Y.-L., & Lu, P.-J. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.06.001 · Cited by 175
Lats2 Is an Essential Mitotic Regulator Required for the Coordination of Cell Division
Yabuta, N., Okada, N., Ito, A., Hosomi, T., Nishihara, S., Sasayama, Y., Fujimori, A., Okuzaki, D., Zhao, H., Ikawa, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608562200 · Cited by 168
The Evolutionary History of YAP and the Hippo/YAP Pathway
Hilman, D., & Gat, U. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr065 · Cited by 166
Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma
Jiang, Z., Li, X., Jin, H., Zhou, W., Jiang, Y., Li, G., & Lu, D. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.09.006 · Cited by 159
Ni, L., Zheng, Y., Hara, M., Pan, D., & Luo, X. (2015) · Genes & Development · doi:10.1101/gad.264929.115 · Cited by 158
Karginov, F. V., & Hannon, G. J. (2013) · Genes & Development · doi:10.1101/gad.215939.113 · Cited by 158
LATS1 tumor suppressor regulates G2/M transition and apoptosis
Hong, X., Qi, H., Li, Y., Pei, J., Barton, J., Blackstad, M., Xu, T., & Tao, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205174 · Cited by 158
Whisnant, A. W., Bogerd, H. P., Flores, O., Ho, P., Powers, J., Sharova, N. P., Stevenson, M., Chen, C., & Cullen, B. R. (2013) · mBio · doi:10.1128/mbio.00193-13 · Cited by 157
Cytoplasmic signalling by the c‐Abl tyrosine kinase in normal and cancer cells
Sirvent, A., Bénistant, C., & Roche, S. (2008) · Biology of the Cell · doi:10.1042/bc20080020 · Cited by 148
Salah, Z., Melino, G., & Aqeilan, R. I. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3516 · Cited by 148
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα
Britschgi, A., Duss, S., Kim, S., Couto, J. P., Brinkhaus, H., Koren, S., Silva, D. D., Mertz, K. D., Kaup, D., Varga, Z., et al. (2017) · Nature · doi:10.1038/nature20829 · Cited by 148
The centrosomal protein Lats2 is a phosphorylation target of Aurora‐A kinase
Toji, S., Yabuta, N., Hosomi, T., Nishihara, S., Kobayashi, T., Suzuki, S., Tamai, K., & Nojima, H. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00732.x · Cited by 145
Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma
Dammann (2009) · Oncology Reports · doi:10.3892/or_00000596 · Cited by 145
The multiple roles of CUX1: Insights from mouse models and cell-based assays
Sansregret, L., & Nepveu, A. (2008) · Gene · doi:10.1016/j.gene.2008.01.017 · Cited by 144
Du, X., Shi, H., Li, J., Dong, Y., Liang, J., Ye, J., Kong, S., Zhang, S., Zhong, T. P., Yuan, Z., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301060 · Cited by 144
Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling
Romano, D., Nguyen, L. K., Matallanas, D., Halász, M., Doherty, C., Kholodenko, B. Ν., & Kölch, W. (2014) · Nature Cell Biology · doi:10.1038/ncb2986 · Cited by 143
Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAPPreprint
Chen, Q., Zhang, N., Xie, R., Wang, W., Cai, J., Choi, K.-S., David, K. K., Huang, B., Yabuta, N., Nojima, H., et al. (2015) · Genes & Development · doi:10.1101/gad.264234.115 · Cited by 143
Cho, W. J., Shin, J. M., Kim, J. S., Lee, M. R., Hong, K. S., Lee, J.-H., Koo, K. H., Park, J. W., & Kim, K.-S. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0158-0 · Cited by 140
Mutant K-Ras Activation of the Proapoptotic MST2 Pathway Is Antagonized by Wild-Type K-Ras
Matallanas, D., Romano, D., Al‐Mulla, F., O’Neill, E. E., Al-Ali, W., Crespo, P., Doyle, B. J., Nixon, C., Sansom, O. J., Drosten, M., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.016 · Cited by 138
Defining the Protein–Protein Interaction Network of the Human Hippo Pathway
Wang, W., Li, X., Huang, J., Feng, L., Dolinta, K., & Chen, J. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030049 · Cited by 136
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability
Ho, K. C., Zhou, Z., She, Y., Chun, A., Cyr, T. D., & Yang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101273108 · Cited by 135
Singh, A., Ramesh, S., Cibi, D. M., Yun, L. S., Li, J., Li, L., Manderfield, L. J., Olson, E. N., Epstein, J. A., & Singh, M. K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.027 · Cited by 135
Lats2 Is a Negative Regulator of Myocyte Size in the Heart
Matsui, Y., Nakano, N., Shao, D., Gao, S., Luo, W., Hong, C., Zhai, P., Holle, E., Yu, X., Yabuta, N., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.180042 · Cited by 133
A kinase shRNA screen links LATS2 and the pRB tumor suppressorPreprint
Tschöp, K., Conery, A. R., Litovchick, L., DeCaprio, J. A., Settleman, J. E., Harlow, E., & Dyson, N. J. (2011) · Genes & Development · doi:10.1101/gad.2000211 · Cited by 130
Regulation of the Mitotic Exit Protein Kinases Cdc15 and Dbf2
Visintin, R., & Amon, A. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.10.2961 · Cited by 130
Wang, G., Jiang, Q., & Zhang, C. (2014) · Journal of Cell Science · doi:10.1242/jcs.151753 · Cited by 127
The Ubiquitin Ligase Siah2 and the Hypoxia Response
Nakayama, K., Qi, J., & Ronai, Z. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0458 · Cited by 126
Yang, X., Li, D., Chen, W., & Xu, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204817 · Cited by 119
Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation
Zhang, K., Rodríguez-Aznar, E., Yabuta, N., Owen, R. J., Mingot, J. M., Nojima, H., Nieto, M. A., & Longmore, G. D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.357 · Cited by 116
Cytoplasmic ASPP1 inhibits apoptosis through the control of YAPPreprint
Vigneron, A. M., Ludwig, R. L., & Vousden, K. H. (2010) · Genes & Development · doi:10.1101/gad.1954310 · Cited by 115
Regulation of ploidy and senescence by the AMPK‐related kinase NUAK1
Humbert, N., Navaratnam, N., Augert, A., Da Costa, M., Martien, S., Wang, J., Martinez, D., Abbadie, C., Carling, D., de Launoit, Y., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.342 · Cited by 115
Yabuta, N., Fujii, T., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Nishiguchi, H., Endo, Y., Toji, S., Tanaka, H., Nishimune, Y., et al. (2000) · Genomics · doi:10.1006/geno.1999.6065 · Cited by 112
Lorthongpanich, C., Messerschmidt, D. M., Chan, S. W., Hong, W., Knowles, B. B., & Solter, D. (2013) · Genes & Development · doi:10.1101/gad.219618.113 · Cited by 110
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation
Aylon, Y., Gershoni, A., Rotkopf, R., Biton, I. E., Porat, Z., Koh, A. P., Sun, X., Lee, Y., Fiel, M.-I., Hoshida, Y., et al. (2016) · European Journal of Cancer · doi:10.1016/s0959-8049(16)61580-0 · Cited by 109
Self-citationNishiyama, Y., Hirota, T., Morisaki, T., Hara, T., Marumoto, T., Iida, S.-I., Makino, K., Yamamoto, H., Hiraoka, T., Kitamura, N., et al. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01224-7 · Cited by 108
Yi, J., Lu, L., Yanger, K., Wang, W., Sohn, B. H., Stanger, B. Z., Zhang, M., Martin, J. F., Ajani, J. A., Chen, J., et al. (2016) · Hepatology · doi:10.1002/hep.28768 · Cited by 108
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
Higashi, T., Hayashi, H., Ishimoto, T., Takeyama, H., Kaida, T., Arima, K., Taki, K., Sakamoto, K., Kuroki, H., Okabe, H., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.170 · Cited by 105
Jiménez‐Velasco, A., Román‐Gómez, J., Agirre, X., Barrios, M., Navarro, G., Vázquez, I., Prósper, F., Torres, A., & Heiniger, A. (2005) · Leukemia · doi:10.1038/sj.leu.2403974 · Cited by 102
Aylon, Y., Ofir-Rosenfeld, Y., Yabuta, N., Lapi, E., Nojima, H., Lü, X., & Oren, M. (2010) · Genes & Development · doi:10.1101/gad.1954410 · Cited by 100
Self-citationPutative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-xL
Ke, H., Pei, J., Ni, Z., Hong, X., Qi, H., Woods, T., Kelekar, A., & Tao, W. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.031 · Cited by 99
Activation of the Yeast Hippo Pathway by Phosphorylation-Dependent Assembly of Signaling Complexes
Lim, D., Stach, L., Ogrodowicz, R. W., Keck, J. M., Jones, M. H., Wong, C. C. L., Yates, J. R., Winey, M., Smerdon, S. J., Rock, J. M., et al. (2013) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 98
WWP1 E3 Ligase Targets LATS1 for Ubiquitin-Mediated Degradation in Breast Cancer Cells
Yeung, B., Ho, K. C., & Yang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061027 · Cited by 96
Ragusa, M., Statello, L., Maugeri, M., Majorana, A., Barbagallo, D., Salito, L., Sammito, M., Santonocito, M., Angelica, R., Cavallaro, A. S., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0918-8 · Cited by 95
Pefani, D., Latusek, R., Pires, I. M., Grawenda, A. M., Yee, K. S. Y., Hamilton, G., van der Weyden, L., Esashi, F., Hammond, E. M., & O’Neill, E. E. (2014) · Nature Cell Biology · doi:10.1038/ncb3035 · Cited by 93
Li, W., Wang, L., Katoh, H., Liu, R., Zheng, P., & Liu, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3268 · Cited by 92
Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming
Qin, H., Blaschke, K., Wei, G., Ohi, Y., Blouin, L., Qi, Z., Yu, J., Yeh, R., Hebrok, M., & Ramalho‐Santos, M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds023 · Cited by 92
Hua, K., Jin, J., Zhao, J., Song, J., Song, H., LI, D., Maskey, N., Zhao, B., Wu, C., Xu, H., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3405 · Cited by 90
NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation
Salah, Z., Cohen, S., Itzhaki, E., & Aqeilan, R. I. (2013) · Cell Cycle · doi:10.4161/cc.26672 · Cited by 89
Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway
Liu, G., Yu, F., Kim, Y. C., Meng, Z., Naipauer, J., Looney, D. J., Liu, X., Gutkind, J. S., Mesri, E. A., & Guan, K.-L. (2014) · Oncogene · doi:10.1038/onc.2014.281 · Cited by 86
The Paradox of p53: What, How, and Why?Preprint
Aylon, Y., & Oren, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026328 · Cited by 81
Self-citationIida, S.-I., Hirota, T., Morisaki, T., Marumoto, T., Hara, T., Kuninaka, S., Honda, S., Kosai, K.-I., Kawasuji, M., Pallas, D. C., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207623 · Cited by 80
Belair, C., Baud, J., Chabas, S., Sharma, C. M., Vogel, J., Staedel, C., & Darfeuille, F. (2011) · Silence · doi:10.1186/1758-907x-2-7 · Cited by 77
Down-regulation of LATS kinases alters p53 to promote cell migrationPreprint
Furth, N., Moshe, N. B. B., Pozniak, Y., Porat, Z., Geiger, T., Domany, E., Aylon, Y., & Oren, M. (2015) · Genes & Development · doi:10.1101/gad.268185.115 · Cited by 75
Self-citationBryant, P. J., Watson, K. L., Justice, R. W., et al. (1993) · Development · doi:10.1242/dev.119.supplement.239 · Cited by 74
The LATS2/KPM Tumor Suppressor Is a Negative Regulator of the Androgen Receptor
Powzaniuk, M., McElwee-Witmer, S., Vogel, R. L., Hayami, T., Rutledge, S. J., Chen, F., Harada, S.-I., Schmidt, A., Rodan, G. A., Freedman, L. P., et al. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0065 · Cited by 74
LATS2 Suppresses Oncogenic Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction
Li, J., Chen, X., Ding, X., Cheng, Y., Zhao, B., Lai, Z.-C., Hezaimi, K. A., Hakem, R., Guan, K., & Wang, C. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.037 · Cited by 74
Huntoon, C. J., Nye, M. D., Geng, L., Peterson, K. L., Flatten, K. S., Haluska, P., Kaufmann, S. H., & Karnitz, L. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1345 · Cited by 73
Deng, J., Wan, L., Xiang, X., Zhang, L., Lei, J., Gong, Y., Song, M., Wang, Y., Fang, Z., Yu, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7048 · Cited by 73
The characterisation of LATS2 kinase regulation in Hippo-YAP signalling
Hoa, L., Kulaberoglu, Y., Gündoğdu, R., Cook, D., Mavis, M., Gómez-Ferrer, M., Gómez, V., & Hergovich, A. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.012 · Cited by 72
Lats2 Modulates Adipocyte Proliferation and Differentiation via Hippo Signaling
An, Y., Kang, Q., Zhao, Y., Hu, X., & Li, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072042 · Cited by 71
Aylon, Y., Yabuta, N., Besserglick, H., Buganim, Y., Rotter, V., Nojima, H., & Oren, M. (2009) · Oncogene · doi:10.1038/onc.2009.270 · Cited by 71
Self-citationReuven, N. B., Adler, J., Meltser, V., & Shaul, Y. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.83 · Cited by 70
Kamikubo, Y., Takaori‐Kondo, A., Uchiyama, T., & Hori, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211974200 · Cited by 70
The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis
Yabuta, N., Mukai, S., Okada, N., Aylon, Y., & Nojima, H. (2011) · Cell Cycle · doi:10.4161/cc.10.16.16873 · Cited by 69
Self-citationHori, T., Takaori‐Kondo, A., Kamikubo, Y., & Uchiyama, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203659 · Cited by 69
NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway
Bae, S. J., Kim, M., Kim, S.-H., Kwon, Y. E., Lee, J.-H., Kim, J., Chung, C. H., Lee, W., & Seol, J. H. (2015) · Nature Communications · doi:10.1038/ncomms7314 · Cited by 68
Lengthening of 3′UTR increases with morphological complexity in animal evolution
Chen, C.-Y., Chen, S., Juan, H., & Huang, H. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts623 · Cited by 68
Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosis
Suzuki, H., Yabuta, N., Okada, N., Torigata, K., Aylon, Y., Oren, M., & Nojima, H. (2013) · Journal of Cell Science · doi:10.1242/jcs.125815 · Cited by 67
Self-citationA critical role for NF2 and the Hippo pathway in branching morphogenesis
Reginensi, A., Enderle, L., Gregorieff, A., Johnson, R. L., Wrana, J. L., & McNeill, H. (2016) · Nature Communications · doi:10.1038/ncomms12309 · Cited by 66
Mitamura, T., Watari, H., Wang, L., Kanno, H., Kitagawa, M., Hassan, M. K., Kimura, T., Tanino, M. A., Nishihara, H., Tanaka, S., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-97 · Cited by 65
Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas
Oh, J., Ohta, T., Satomi, K., Foll, M., Durand, G., McKay, J., Calvez‐Kelm, F. L., Mittelbronn, M. G. A., Brokinkel, B., Paulus, W., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000238 · Cited by 64
Zhang, M., Wang, X., Li, W., & Cui, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.110 · Cited by 60
Newcomers to the WW Domain-Mediated Network of the Hippo Tumor Suppressor Pathway
Sudol, M. (2010) · Genes & Cancer · doi:10.1177/1947601911401911 · Cited by 60
Underexpression ofLATS1TSG in colorectal cancer is associated with promoter hypermethylation
Wierzbicki, P. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i27.4363 · Cited by 58
Role of Angiomotin‐like 2 mono‐ubiquitination on YAP inhibition
Kim, M., Kim, M., Park, S., Lee, C., & Lim, D. (2015) · EMBO Reports · doi:10.15252/embr.201540809 · Cited by 58
Grieve, S., Zhou, Z., She, Y., Huang, H., Cyr, T. D., Xu, T., & Yang, X. (2011) · Cell Research · doi:10.1038/cr.2011.122 · Cited by 56
Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
Kawahara, M., Hori, T., Chonabayashi, K., Oka, T., Sudol, M., & Uchiyama, T. (2008) · Blood · doi:10.1182/blood-2007-09-111773 · Cited by 56
LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma
Stražišar, M., Mlakar, V., & Glavač, D. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.09.011 · Cited by 54
Zhang, L., Iyer, J., Chowdhury, A., Ji, M. H., Xiao, L., Yang, S., Chen, Y., Tsai, M.-Y., & Dong, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385518 · Cited by 52
Stability of the LATS2 Tumor Suppressor Gene Is Regulated by Tristetraprolin
Lee, H. H., Vo, M., Kim, H. J., Lee, U. H., Kim, C. W., Kim, H. K., Ko, M. S., Lee, W. H., Cha, S. J., Min, Y. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094235 · Cited by 50
MicroRNA-103 promotes tumor growth and metastasis in colorectal cancer by directly targeting LATS2
Zheng, Y., Xiao, K., Xiao, G.-C., Tong, S., Ding, Y., Wang, Q., Li, S., & Hao, Z.-N. (2016) · Oncology Letters · doi:10.3892/ol.2016.4814 · Cited by 49
Expression of the Argonaute protein PiwiL2 and piRNAs in adult mouse mesenchymal stem cells
Wu, Q., Ma, Q., Shehadeh, L. A., Wilson, A., Xia, L.-H., Yu, H., & Webster, K. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.022 · Cited by 48
Park, G.-S., Oh, H., Kim, M., Kim, T., Johnson, R. L., Irvine, K. D., & Lim, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8211 · Cited by 48
Tian, Y., Bachman, J. F., & Lai, Z.-C. (2014) · Protein & Cell · doi:10.1007/s13238-014-0122-4 · Cited by 46
N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability
Yabuta, N., Mukai, S., Okamoto, A., Okuzaki, D., Suzuki, H., Torigata, K., Yoshida, K., Okada, N., Miura, D., Ito, A., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.113431 · Cited by 46
Fang, X., & Adler, P. N. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.02.029 · Cited by 45
WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis
Morisaki, T., Hirota, T., Iida, S.-I., Marumoto, T., Hara, T., Nishiyama, Y., Kawasuzi, M., Hiraoka, T., Mimori, T., Araki, N., et al. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03360-4 · Cited by 44
Chen, K.-H., HE, J., Wang, D., CAO, J.-J., LI, M.-C., Zhao, X., SHENG, X., Li, W., & Liu, W. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2687 · Cited by 44
The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death
Kuninaka, S., Nomura, M., Hirota, T., Iida, S.-I., Hara, T., Honda, S., Kunitoku, N., Sasayama, T., Arima, Y., Marumoto, T., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208682 · Cited by 43
Isolation and characterization of sixteen novel p53 response genes
Kostic, C., & Shaw, P. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203747 · Cited by 43
Dewey, E. B., Sanchez, D., & Johnston, C. A. (2015) · Current Biology · doi:10.1016/j.cub.2015.09.025 · Cited by 38
Preferential regulation of duplicated genes by microRNAs in mammals
Li, J., Musso, G. A., & Zhang, Z. (2008) · Genome biology · doi:10.1186/gb-2008-9-8-r132 · Cited by 37
Luo, Z.-L., Luo, H., Chen, F., Cheng, L., Huang, Z., Dai, R., Li, K., Tian, F., Wang, T., & Tang, L. (2015) · Oncotarget · doi:10.18632/oncotarget.6395 · Cited by 37
A novel Chk1/2–Lats2–14-3-3 signaling pathway regulates P-body formation in response to UV damage
Okada, N., Yabuta, N., Suzuki, H., Aylon, Y., Oren, M., & Nojima, H. (2010) · Journal of Cell Science · doi:10.1242/jcs.072918 · Cited by 36
Self-citationDual function of partitioning-defective 3 in the regulation of YAP phosphorylation and activation
Zhang, P., Wang, S., Wang, S., Qiao, J., Zhang, L., Zhang, Z., & Chen, Z. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.21 · Cited by 36
Lats2 is critical for the pluripotency and proper differentiation of stem cells
Aylon, Y., Sarver, A. L., Tovy, A., Ainbinder, E., & Oren, M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2013.188 · Cited by 31
Self-citationLats1 suppresses centrosome overduplication by modulating the stability of Cdc25B
Mukai, S., Yabuta, N., Yoshida, K., Okamoto, A., Miura, D., Furuta, Y., Abe, T., & Nojima, H. (2015) · Scientific Reports · doi:10.1038/srep16173 · Cited by 30
An indirect role for ASPP1 in limiting p53‐dependent p21 expression and cellular senescence
Vigneron, A. M., & Vousden, K. H. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.402 · Cited by 26
Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice
Siam, R., Harada, R., Cadieux, C., Battat, R. J., Vadnais, C., & Nepveu, A. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-60 · Cited by 23
Ce‐wts‐1 plays important roles in Caenorhabditis elegans development
Cai, Q., Wang, W., Gao, Y. D., Yang, Y., Zhu, Z., & Fan, Q. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.09.002 · Cited by 22
Ishizaki, K., Fujimoto, J., Kumimoto, H., Nishimoto, Y., Shimada, Y., Shinoda, M., & Yamamoto, T. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.5.1053 · Cited by 22
Hypermethylation of the large tumor suppressor genes in Japanese lung cancer
Sasaki, H., Hikosaka, Y., Kawano, O., Yano, M., & Fujii, Y. (2010) · Oncology Letters · doi:10.3892/ol_00000054 · Cited by 18
N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability
Yabuta, N., Mukai, S., Okamoto, A., Okuzaki, D., Suzuki, H., Torigata, K., Yoshida, K., Okada, N., Miura, D., Ito, A., et al. (2013) · Development · doi:10.1242/dev.096842 · Cited by 18
Contribution of LATS1 and LATS2 promoter methylation in OSCC development
Rigi‐Ladiz, M. A., Najafi, M., & Kordi-Tamandani, D. M. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0356-4 · Cited by 18
Masuda, K., Chiyoda, T., Sugiyama, N., Segura‐Cabrera, A., Kabe, Y., Ueki, A., Banno, K., Suematsu, M., Aoki, D., Ishihama, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118662 · Cited by 16
APOBEC3 inhibits DEAD-END function to regulate microRNA activity
Ali, S., Karki, N., Bhattacharya, C., Zhu, R., MacDuff, D. A., Stenglein, M. D., Schumacher, A. J., Demorest, Z. L., Harris, R. S., Matin, A., et al. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-16 · Cited by 16
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
YAP/TAZ upstream signals and downstream responses
Totaro, A., Panciera, T., & Piccolo, S. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0142-z · Cited by 1,086
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 326
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver
Fan, W., Adebowale, K., Váncza, L., Li, Y., Rabbi, M. F., Kunimoto, K., Chen, D., Mozes, G., Chiu, D. K.-C., Li, Y., et al. (2024) · Nature · doi:10.1038/s41586-023-06991-9 · Cited by 263
Insights into recent findings and clinical application of YAP and TAZ in cancer
Franklin, J. M., Wu, Z., & Guan, K.-L. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00579-1 · Cited by 213
Metadata
- Authors
- Furth, N., & Aylon, Y.
- Venue
- Cell Death & Differentiation
- Published
- 2017-06-23
- Volume
- 24
- Issue
- 9
- Pages
- 1488-1501
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2719863387
- Cited by
- 260
- References
- 204
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.